- Home
- TROO vs PLRX Comparison
TROO vs PLRX Comparison
Compare TROO & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TROO
- PLRX
- Stock Information
- Founded
- TROO 2005
- PLRX 2015
- Country
- TROO Hong Kong
- PLRX United States
- Employees
- TROO N/A
- PLRX N/A
- Industry
- TROO Radio And Television Broadcasting And Communications Equipment
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- TROO Technology
- PLRX Health Care
- Exchange
- TROO Nasdaq
- PLRX Nasdaq
- Market Cap
- TROO 166.5M
- PLRX 165.5M
- IPO Year
- TROO N/A
- PLRX 2020
- Fundamental
- Price
- TROO $0.77
- PLRX $1.47
- Analyst Decision
- TROO
- PLRX Hold
- Analyst Count
- TROO 0
- PLRX 10
- Target Price
- TROO N/A
- PLRX $9.79
- AVG Volume (30 Days)
- TROO 292.6K
- PLRX 3.4M
- Earning Date
- TROO 04-28-2025
- PLRX 03-03-2025
- Dividend Yield
- TROO N/A
- PLRX N/A
- EPS Growth
- TROO N/A
- PLRX N/A
- EPS
- TROO N/A
- PLRX N/A
- Revenue
- TROO $4,344,000.00
- PLRX N/A
- Revenue This Year
- TROO N/A
- PLRX N/A
- Revenue Next Year
- TROO N/A
- PLRX $46.66
- P/E Ratio
- TROO N/A
- PLRX N/A
- Revenue Growth
- TROO 14.77
- PLRX N/A
- 52 Week Low
- TROO $0.73
- PLRX $1.26
- 52 Week High
- TROO $4.89
- PLRX $16.52
- Technical
- Relative Strength Index (RSI)
- TROO 25.44
- PLRX 26.84
- Support Level
- TROO $0.75
- PLRX $1.42
- Resistance Level
- TROO $1.53
- PLRX $1.78
- Average True Range (ATR)
- TROO 0.13
- PLRX 0.13
- MACD
- TROO -0.01
- PLRX 0.26
- Stochastic Oscillator
- TROO 2.55
- PLRX 14.08
About TROO TROOPS Inc.
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.